Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-0516-2026

Medline Industries, LP recalls MEDLINE convenience kits labeled as: 1) HEAD AND NECK

Medline Industries, LPNorthfield, IL, United StatesReported Nov 26, 2025 · 7 months ago
Legal News Analyst ·

Reason for recall

Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing SafeAir Smoke Evacuation Pencils. Stryker Instruments has expanded the scope of their recall of SafeAir Smoke Evacuation Pencils previously initiated in October 2024, adding an additional 47 lots to the scope of the recall. The initial recall was due to the potential for product to activate without manual input when plugged into a power source or remain active after buttons are released.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

MEDLINE convenience kits labeled as: 1) HEAD AND NECK, REF CDS984259O; 2) HEAD AND NECK, REF CDS984259P; 3) MINOR ENT HARPER PACK-LF, REF DYNJ0160700F; 4) MAJOR ENT HARPER PACK-LF, REF DYNJ0161710I; 5) THORACOTOMY HARPER PACK-LF, REF DYNJ0161795F; 6) MAJOR ENT MZ PACK-LF, REF DYNJ0429404O; 7) MAJOR ENT MB PACK-LF, REF DYNJ0429404P; 8) THYROID MOFF PACK-LF, REF DYNJ0429430S; 9) NASALPLASTY #61-RF, REF DYNJ27320V; 10) MIDDLE EAR PACK, REF DYNJ55235C; 11) HEAD AND NECK, REF DYNJ64235B; 12) NECK PACK SRM-LF, REF DYNJ65020C; 13) ACH HEAD & NECK PACK-LF, REF DYNJ67754B; 14) ENT HEAD NECK PACK, REF DYNJ68211B; 15) OSC ENT HEAD PACK, REF DYNJ68957B; 16) EAR UM-LF, REF DYNJ902331D; 17) HEAD&NECK, REF DYNJ906655G; 18) ENT-LF, REF DYNJ907577; 19) MAJOR HEAD AND NECK PPS, REF DYNJ9425991Q; 20) MINOR ENT # 56653-LF, REF DYNJVB91072A.

Lot / code information

REF
CDS984259O: UDI/DI 10195327297817 (each), 40195327297818 (case)
Lot #
23FBR754, 23GBH766, 24ABP608, 24BBN514; 2)
REF
CDS984259P: UDI/DI 10195327647827 (each), 40195327647828 (case)
Lot #
24DBQ755; 3)
REF
DYNJ0160700F: UDI/DI 10195327304294 (each), 40195327304295 (case)
Lot #
23FDA156, 23GDA649; 4)
REF
DYNJ0161710I: UDI/DI 10195327375003 (each), 40195327375004 (case)
Lot #
23EDB639, 23FDA196, 23GDA674; 5)
REF
DYNJ0161795F: UDI/DI 10195327375010 (each), 40195327375011 (case)
Lot #
23FDA246, 23HDA365; 6)
Show 30 more code fields
REF
DYNJ0429404O: UDI/DI 10195327050092 (each), 40195327050093 (case)
Lot #
23GMI073, 23JMC414, 23LMA073; 7)
REF
DYNJ0429404P: UDI/DI 10195327587581 (each), 40195327587582 (case)
Lot #
23LMH745, 24BME178, 24DMF230; 8)
REF
DYNJ0429430S: UDI/DI 10195327689841 (each), 40195327689842 (case)
Lot #
24LME516; 9)
REF
DYNJ27320V: UDI/DI 10195327104719 (each), 40195327104710 (case)
Lot #
23GBT502, 24ABD023, 24ABX584, 24DBA020, 24DBU467, 24FBD739; 10)
REF
DYNJ55235C: UDI/DI 10195327412081 (each), 40195327412082 (case)
Lot #
23GBN444, 23IBU467; 11)
REF
DYNJ64235B: UDI/DI 10193489382662 (each), 40193489382663 (case)
Lot #
23FMB928; 12)
REF
DYNJ65020C: UDI/DI 10195327528218 (each), 40195327528219 (case)
Lot #
23JMD840, 23LME135, 24FMH184; 13)
REF
DYNJ67754B: UDI/DI 10195327227982 (each), 40195327227983 (case)
Lot #
23EBK256, 23HBM886, 23IBP461, 23JBR528; 14)
REF
DYNJ68211B: UDI/DI 10195327352493 (each), 40195327352494 (case)
Lot #
23HMC691; 15)
REF
DYNJ68957B: UDI/DI 10195327512033 (each), 40195327512034 (case)
Lot #
23JMD230, 24AMB618; 16)
REF
DYNJ902331D: UDI/DI 10195327698089 (each), 40195327698080 (case)
Lot #
24EBC946, 24EBV522; 17)
REF
DYNJ906655G: UDI/DI 10195327301835 (each), 40195327301836 (case)
Lot #
24ADB523; 18)
REF
DYNJ907577: UDI/DI 10193489437713 (each), 40193489437714 (case)
Lot #
23GBB195, 23GBN735; 19)
REF
DYNJ9425991Q: UDI/DI 10195327587604 (each), 40195327587605 (case)
Lot #
24ALB133; 20)
REF
DYNJVB91072A: UDI/DI 10195327466428 (each), 40195327466429 (case)
Lot #
23HLB079, 23ILA192, 24ALA650

What the firm is doing

Medline issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 09/30/2025 and 10/6/2025 via email and mail. The notice explained the issue with the component, potential risk, and requested the following actions: 1. Immediately check stock for the affected item number(s) and the affected lot number(s) listed within the recall portal. Quarantine all affected product. 2. Please use the link and the information found in the notice to complete the response form. Please list the quantity of affected product in inventory on the form. Even if no affected product is in inventory, please complete and submit the form. 3. Upon receipt of the submitted response form, the customer account will receive over-labels to place on affected inventory, with instructions for the customer staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. 4. For distributors or those who have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please include your customers quantities on your response form. Upon receipt of your submitted response form, you will receive over-labels to provide to your customers to affix to their affected product. If you have any questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.

DistributionShow details

US Nationwide distribution.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls